liver cancer

37 проекта

HEИндивидуална стипендия2027–2028Италия

RESIST-CCA · Unravelling Malignant Cholangiocyte Subpopulations that Drive Chemoresistance in Cholangiocarcinoma

HEИндивидуална стипендия2027–2029Испания

IRM · Glutaminase Isoenzymes: Gatekeepers of Bioenergetics, Immunity, and Tumor Microenvironment in Diabetes-Induced Hepatocellular Carcinoma

HEИндивидуална стипендия2026–2028Германия

EpiGen-LC · Epigenetic and Genetic interplay in Liver Cancer

HEИндивидуална стипендия2025–2027Белгия

DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments

H2020Индивидуална стипендия2021–2023Франция

Multi-IF · Multicolor Fluorescent Ultrashort Carbon Nanotubes for Multiplexed immunofluorescence in Cancer Diagnostics

H2020Докторантска мрежа2019–2022Нидерландия

ElectroPros · Training research pioneers by utilizing and validating the promise of electroporation for minimal invasive oncological treatments.

3 партньори · 2 държави

H2020Индивидуална стипендия2019–2021Швейцария

mTORmorS · Role of mTOR signaling dysregulation in the tumor suppressor networks in hepatocellular carcinoma

H2020Обмен на изследователи2018–2022Франция

COCLICAN · COllaborative Consortium for the early detection of LIver CANcer

8 партньори · 5 държави

H2020Докторантска мрежа2017–2021Испания

VIRO-FLOW · Enabling Technologies and Drug Discovery: Continuous Flow Processes to Discover Novel Antiviral Inhibitors

2 партньори · 2 държави

H2020Индивидуална стипендия2017–2019Швейцария

ADVaNCE · ADVerse outcome Network for non-mutagenic CarcinogEns

H2020Индивидуална стипендия2017–2020Дания

MiRCHOL · Mechanistic and therapeutic implications of microRNA deregulation for drug resistance in bile duct cancer

H2020Докторантска мрежа2017–2021Португалия

Foie Gras · Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease

14 партньори · 8 държави

H2020Индивидуална стипендия2016–2018Обединеното кралство

EXNADMINA · EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease

H2020Докторантска мрежа2016–2021Норвегия

HiPerNav · High Performance Soft-tissue Navigation

14 партньори · 6 държави

H2020Индивидуална стипендия2016–2018Италия

ENVERESP · Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity

H2020Индивидуална стипендия2016–2018Обединеното кралство

EPILIPRO · Elucidating the role of Arid1a in adult liver

H2020Индивидуална стипендия2016–2018Дания

EpiLIVER · Characterization and implications of DNA damage response in liver cancer

H2020Индивидуална стипендия2016–2017Белгия

REZONABLE · Regeneration and zonation by ZEB2 of Liver Endothelium

H2020Индивидуална стипендия2016–2018Обединеното кралство

mini-liver SCCS · Human “mini-liver” stem cell culture systems: from mechanisms behind liver cancer origin and recurrence to new therapeutic treatments

H2020Индивидуална стипендия2015–2017Белгия

LiVirIn · 3D Liver Organoids: Modelling Host Hepatitis B Virus Interaction

H2020Индивидуална стипендия2015–2018Испания

TARGEPILIVER · Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

H2020Индивидуална стипендия2015–2017Гърция

EpiNKT · Transcriptional and epigenetic control of innate-like T lymphocyte development

FP7Индивидуална стипендия2014–2016Швеция

INTERDRUG · Epigenetic mechanisms underlying inter-individual differences in drug response and hepatic disease

FP7Индивидуална стипендия2014–2016Обединеното кралство

NANODISCAN · Nano-technology enabled repositioning of Disulfiram as an anti-cancer stem cell agent